Present findings suggest a causal, direct relationship between Artemether-induced activation of AMPK and the neuroprotective effect towards Aβ1-42 insult and the neurotherapeutic effect in 3xTg-AD mouse model. This evidence concerns the gene PRKAA2 and Alzheimer disease.